Clinical trial
Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of…
NCT00152399 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00152399 |
|---|---|
| Title | Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial To Study The Efficacy And The Safety Of The Early Administration Of Somatostatin (Ucb) 12 Mg/24 H IV Infusion And Two IV Boluses Of 250 Mcg During 72 Hours In The Treatment Of Subjects With Acute Severe Upper Gastrointestinal Bleeding… |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Peptic Ulcer |
| Intervention type | Drug |
| Interventions | Somatostatin UCB (drug) |
| Enrollment | 370 |
| Start date | Sep 1, 2000 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Sep 9, 2005 |
| Last update posted | Sep 18, 2012 |
| Countries | Belgium, France, Greece, Hungary, Poland, Spain |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: